NDC36000-0308-10: NALOXONE HYDROCHLORIDE INJECTION.
NALOXONE HYDROCHLORIDE INJECTION. Key specifications include special_features: FLIPTOP VIAL, primary_container_type: VIAL, protective_storage_feature: SUBJECT TO DAMAGE BY FREEZING, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, total_primary_container_quantity: 10, primary_container_content_quantity: 1.000 MILLILITERS. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-533-4126, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| special_features | FLIPTOP VIAL |
| primary_container_type | VIAL |
| protective_storage_feature | SUBJECT TO DAMAGE BY FREEZING |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| total_primary_container_quantity | 10 |
| primary_container_content_quantity | 1.000 MILLILITERS |
| active_medicament_medicinal_strength | 0.400 MILLIGRAMS NALOXONE HYDROCHLORIDE PER MILLILITER |
| part_name_assigned_by_controlling_agency | NALOXONE HYDROCHLORIDE INJ 0.4 MG/ML 1ML VI 10S |
| american_hospital_formulary_service_classification_number | 281000 |
| NSN | 6505-01-533-4126 |
| PRIMARY CONTAINER CONTENT QUANTITY | 1.000 MILLILITERS |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| PRIMARY CONTAINER TYPE | VIAL |
| SPECIAL FEATURES | FLIPTOP VIAL |
| PROTECTIVE STORAGE FEATURE | SUBJECT TO DAMAGE BY FREEZING |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | NALOXONE HYDROCHLORIDE INJ 0.4 MG/ML 1ML VI 10S |
| AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER | 281000 |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 0.400 MILLIGRAMS NALOXONE HYDROCHLORIDE PER MILLILITER |
| TOTAL PRIMARY CONTAINER QUANTITY | 10 |